News & Media
Michelson Diagnostics Ltd awarded LDA Grant
Start-up Michelson Diagnostics Ltd has been awarded a £140k Grant for Research & Development by the London Development Agency.
The SE-London based company will use the funding to support the development of a prototype medical scanner to be used in lung cancer surgery.
Michelson Diagnostics aims to address the huge potential market for a non-invasive alternative to surgical biopsy in many clinical applications such as lung, cervical, oesophageal and skin cancer.
Applications Director Dr Gordon McKenzie said, "Clinicians we are working with are very excited that by using our equipment, they will be able to see the tell-tale signs of tumour growth without causing the patient the pain and stress of a biopsy."
Their technology is based on 'Optical Coherence Tomography' and enables images of sub-surface tissue structure to be captured and displayed at far higher resolution than available from ultrasound, PET or MRI scanners.
The prototype will be used to demonstrate that real-time images of clinical quality can be obtained.
